Shandong Jincheng Pharmaceutical and Chemical Co Ltd - Asset Resilience Ratio
Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has an Asset Resilience Ratio of 3.45% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shandong Jincheng Pharmaceutical and Che working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2025–2025)
This chart shows how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Shandong Jincheng Pharmaceutical and Che.
Liquid Assets Composition Over Time
This chart breaks down Shandong Jincheng Pharmaceutical and Chemical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Shandong Jincheng Pharmaceutical and Che (300233) long-term investment share to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥180.00 Million | 3.45% |
| Total Liquid Assets | CN¥180.00 Million | 3.45% |
Asset Resilience Insights
- Limited Liquidity: Shandong Jincheng Pharmaceutical and Chemical Co Ltd maintains only 3.45% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Shandong Jincheng Pharmaceutical and Chemical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen Senior Technology Material Co Ltd
SHE:300568 |
Chemicals | 0.92% |
|
Shaanxi Lighte Optoelectronics Material Co. Ltd. A
SHG:688150 |
Chemicals | 20.97% |
|
Guangzhou Lingwe Technology Co. Ltd. A
SHE:301373 |
Chemicals | 4.34% |
|
Guangdong Rongtai Industry Co Ltd
SHG:600589 |
Chemicals | 0.00% |
|
Darbond Technology Co. Ltd. A
SHG:688035 |
Chemicals | 11.22% |
|
Jingsu Jingshen Salt&Chem
SHG:603299 |
Chemicals | 2.88% |
|
GRIPM Advanced Materials Co. Ltd. A
SHG:688456 |
Chemicals | 0.15% |
|
Shandong Kaisheng New Materials Co.Ltd.
SHE:301069 |
Chemicals | 20.69% |
Annual Asset Resilience Ratio for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2025–2025)
The table below shows the annual Asset Resilience Ratio data for Shandong Jincheng Pharmaceutical and Chemical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.35% | CN¥70.00 Million ≈ $10.24 Million |
CN¥5.19 Billion ≈ $759.59 Million |
-- |
About Shandong Jincheng Pharmaceutical and Chemical Co Ltd
Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China.